October 10, 2025 FDA Broadens Label for Schizophrenia Drug The FDA has approved a new long-acting injectable treatment option for adults with bipolar I disorder. Conexiant
October 10, 2025 Panel Finalizes 6 Cannabis Competencies For US Med Schools New framework guides medical schools in teaching evidence-based cannabis education. Conexiant
October 03, 2025 Autism Trajectories: What the Data Suggest Two genetic factors may shape autism’s age of diagnosis and mental health overlap. Conexiant
September 29, 2025 Levodopa Investigated for Stroke Rehabilitation: ESTREL Trial Swiss trial across 13 stroke units and 11 rehab centers challenges levodopa use in stroke recovery. Conexiant
September 23, 2025 AI Model Predicts Multiple Disease Risk Delphi-2M transformer, trained on nearly 2 million patients, predicts disease progression and mortality risk years in advance Conexiant
September 18, 2025 Cuts or Care: ‘What Are the Priorities?’ New residency programs launch as Northern California faces ongoing physician shortages and potential funding reductions. KFF Health News
September 18, 2025 Semaglutide Reduced HbA1c, Weight in Schizophrenia First trial shows semaglutide maintains psychiatric stability while improving metabolic outcomes in patients with schizophrenia. Conexiant
September 17, 2025 ‘Death by a Thousand Cuts’ Rural South Texas hospitals and physicians face mounting strain as rising uninsured rates and federal funding cuts threaten access to essential health care. KFF Health News
September 17, 2025 Global Survey Finds Suicidal Ideation Risk With Atopic Eczema Obesity, severe disease, and insomnia raise suicidal ideation risk in atopic eczema Conexiant